We are live on ! Find out more
PTVE

Pactiv Evergreen Inc. Common stock

Delisted

PTVE was delisted on the 31st of March, 2025.

127 hedge funds and large institutions have $596M invested in Pactiv Evergreen Inc. Common stock in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,800% more call options, than puts

Call options by funds: $931K | Put options by funds: $49K

155% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 11

85% more capital invested

Capital invested by funds: $322M → $596M (+$274M)

24% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 38

14% more funds holding

Funds holding: 111127 (+16)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
127
Holders Change
+16
Holders Change %
+14.41%
% of All Funds
1.85%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
28
Increased
47
Reduced
38
Closed
11
Calls
$931K
Puts
$49K
Net Calls
+$882K
Net Calls Change
+$786K
Name Holding Trade Value Shares
Change
Change in
Stake
Los Angeles Capital Management
26
Los Angeles Capital Management
California
$2.48M +$1.9M +180,768 New
JCA
27
Jade Capital Advisors
New Jersey
$2.47M -$1.58M -150,000 -45%
JP Morgan Chase
28
JP Morgan Chase
New York
$2.29M +$1.15M +108,875 +186%
AQR Capital Management
29
AQR Capital Management
Connecticut
$2.14M -$1.19M -113,033 -42%
Invesco
30
Invesco
Georgia
$2.01M +$233K +22,113 +18%
N
31
Nuveen
North Carolina
$1.8M +$205K +19,502 +17%
Barclays
32
Barclays
United Kingdom
$1.71M +$894K +84,925 +215%
CIC
33
Cornercap Investment Counsel
Georgia
$1.58M +$44K +4,179 +4%
Citadel Advisors
34
Citadel Advisors
Florida
$1.43M +$454K +43,153 +70%
Millennium Management
35
Millennium Management
New York
$1.42M +$1.09M +103,856 New
Goldman Sachs
36
Goldman Sachs
New York
$1.42M -$264K -25,041 -19%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$1.22M +$939K +89,161 New
Swiss National Bank
38
Swiss National Bank
Switzerland
$1.2M -$106K -10,100 -10%
AG
39
Algert Global
California
$1.1M -$433K -41,075 -34%
Bank of America
40
Bank of America
North Carolina
$1.08M +$54.7K +5,198 +7%
CSS
41
Cubist Systematic Strategies
Connecticut
$1.04M +$674K +64,012 +548%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$1.02M +$37K +3,516 +5%
GCP
43
GSA Capital Partners
United Kingdom
$990K -$211K -20,020 -22%
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$885K -$108K -10,303 -14%
Tudor Investment Corp
45
Tudor Investment Corp
Connecticut
$861K -$866K -82,255 -57%
Two Sigma Advisers
46
Two Sigma Advisers
New York
$821K +$57.9K +5,500 +10%
CS
47
Credit Suisse
Switzerland
$728K -$296K -28,121 -35%
B
48
Bailard
California
$716K +$355K +33,688 +182%
UBS Group
49
UBS Group
Switzerland
$703K +$244K +23,196 +83%
EI
50
Ethic Inc
New York
$697K +$81K +7,695 +18%

PTVE Hedge Fund Activity: Q4 2023 in Review

127 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q4 2023, worth a combined $596M — up 85% from $322M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new PTVE positions and 11 closed out — a net gain of 17 holders — while 47 added to existing stakes and 38 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $43.1M. The largest seller was EVR Research, cutting an estimated $11.8M.

  • 127 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q4 2023, up from 111 in Q3 2023.
  • Funds reported $596M of Pactiv Evergreen Inc. Common stock stock for Q4 2023, up 85% quarter-over-quarter.
  • 28 funds opened new Pactiv Evergreen Inc. Common stock positions in Q4 2023 and 11 closed out, a net change of +17 holders.
  • The largest Pactiv Evergreen Inc. Common stock buyer in Q4 2023 was Morgan Stanley, an estimated $43.1M added.
  • The largest Pactiv Evergreen Inc. Common stock seller in Q4 2023 was EVR Research, an estimated $11.8M sold.

Based on aggregated 13F filings for Q4 2023.